Loading…
Indaptus Therapeutics, Inc. is projected to rise to $1.62 by 2027, a +28% move from its current price of $1.27. INDP is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.18 | $1.27 | $1.37 | -0.07% |
| May 30 | $1.14 | $1.27 | $1.41 | -0.14% |
| May 31 | $1.11 | $1.27 | $1.45 | -0.21% |
| Jun 1 | $1.09 | $1.27 | $1.47 | -0.28% |
| Jun 2 | $1.07 | $1.27 | $1.50 | -0.35% |
| Jun 3 | $1.05 | $1.26 | $1.52 | -0.42% |
| Jun 4 | $1.03 | $1.26 | $1.55 | -0.49% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.03 | $1.26 | $1.55 | -0.49% |
| Week 2 | $0.9461 | $1.26 | $1.67 | -0.97% |
| Week 3 | $0.8832 | $1.25 | $1.77 | -1.45% |
| Week 4 | $0.8327 | $1.25 | $1.86 | -1.93% |
| Week 5 | $0.7902 | $1.24 | $1.94 | -2.40% |
| Week 6 | $0.7533 | $1.23 | $2.02 | -2.88% |
| Week 7 | $0.7206 | $1.23 | $2.09 | -3.35% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Indaptus Therapeutics, Inc. is a clinical biotechnology company focused on immunotherapy products for cancer and viral infections. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors.
The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
INDP trades as a healthcare stock with a current price of $1.22 and a market capitalization of $138.16M. It holds the rank of 4070. The asset operates within the Healthcare category and is subject to the broader dynamics of clinical biotechnology development and immunotherapy research.
A major floor 16.5% below — a decisive break under it would weaken the trend.
The nearest floor, 16.5% below — buyers have tended to step in here.
The nearest ceiling, 184.3% above — a clean break opens room to run.
A major ceiling 256.7% above — clearing it would confirm fresh momentum.
Key INDP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INDP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.18 | Buy | $1.24 | Buy |
| MA 10 | $1.38 | Sell | $1.40 | Sell |
| MA 20 | $1.77 | Sell | $1.69 | Sell |
| MA 50 | $2.09 | Sell | $2.00 | Sell |
| MA 100 | $2.16 | Sell | $2.38 | Sell |
| MA 200 | $2.87 | Sell | $4.85 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.29 | Neutral |
| Stoch RSI (14) | 68.94 | Neutral |
| CCI (20) | -85.12 | Neutral |
| Williams %R (14) | -78.35 | Info |
| MACD (12,26,9) | -0.07 | Sell |
| ROC (12) | -32.45 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 21.65 | Neutral |
| TRIX (15) | -1.68 | Sell |
| Awesome (5,34) | -1.08 | Sell |
| Ultimate (7,14,28) | 29.81 | Buy |
| Momentum (10) | -0.46 | Sell |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 1.08 | Buy |
| ADX (14) | 33.93 | Sell |
| ATR (14) | 0.13 | Info |
The near-term technical picture is neutral. The RSI14 stands at 30, and the stock is trading below the SMA50 of $2.11 and the SMA200 of $2.93. This suggests modest near-term momentum with a sub-2.00 price range still in play.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.06 | $1.27 | $2.17 | 0% | Neutral | |
| $1.17 | $1.62 | $2.44 | +28% | Bullish | |
| $1.14 | $1.68 | $2.69 | +33% | Bullish | |
| $1.04 | $1.61 | $2.70 | +27% | Bullish | |
| $0.9168 | $1.49 | $2.60 | +17% | Neutral | |
| $0.7887 | $1.34 | $2.42 | +6% | Neutral | |
| $0.7915 | $1.40 | $2.61 | +10% | Neutral | |
| $1.07 | $1.98 | $3.78 | +56% | Bullish | |
| $1.12 | $2.15 | $4.21 | +69% | Bullish | |
| $1.06 | $2.11 | $4.23 | +66% | Bullish | |
| $1.07 | $2.37 | $5.22 | +87% | Bullish | |
| $1.98 | $4.40 | $10.12 | +247% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.06 | $1.27 | $1.51 | +0.00% |
| June 2026 | $1.01 | $1.21 | $1.51 | -4.37% |
| July 2026 | $0.9773 | $1.19 | $1.52 | -1.85% |
| August 2026 | $1.07 | $1.32 | $1.72 | +11.03% |
| September 2026 | $1.13 | $1.41 | $1.86 | +6.74% |
| October 2026 | $1.11 | $1.40 | $1.87 | -1.01% |
| November 2026 | $1.15 | $1.46 | $1.98 | +4.56% |
| December 2026 | $1.23 | $1.58 | $2.17 | +8.29% |
Click any year to see its month-by-month INDP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, INDP could reach as high as $2.17, with a base case around $1.27 and support toward $1.06 — roughly 0% from $1.27. Price action looks broadly range-bound.
Expect INDP to range from $1.17 to $2.44 through 2027. The $1.62 average target implies a +28% move from current prices. That is up +28% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The INDP price prediction for 2028 points to an average of $1.68 (low $1.14, high $2.69) — a potential gain of +33% on today's $1.27. Momentum favours further upside here.
In 2029, INDP is projected to trade between $1.04 and $2.70, averaging $1.61 — a potential gain of +27% from today's $1.27. That is -4% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
Indaptus Therapeutics, Inc.'s 2030 outlook centres on $1.49, within a $0.9168 to $2.60 range. That is -7% versus the projected 2029 average. That marks a +17% change versus current levels. Price action looks broadly range-bound.
By 2031, INDP could reach as high as $2.42, with a base case around $1.34 and support toward $0.7887 — roughly +6% from $1.27. A consolidation phase looks the most probable path here.
Expect INDP to range from $0.7915 to $2.61 through 2032. The $1.40 average target implies a +10% move from current prices. That is up +5% on the projected 2031 average. Price action looks broadly range-bound.
The INDP price prediction for 2033 points to an average of $1.98 (low $1.07, high $3.78) — a potential gain of +56% on today's $1.27. Buyers look set to stay in control over this stretch.
In 2034, INDP is projected to trade between $1.12 and $4.21, averaging $2.15 — a potential gain of +69% from today's $1.27. That is up +9% on the projected 2033 average. Momentum favours further upside here.
Indaptus Therapeutics, Inc.'s 2035 outlook centres on $2.11, within a $1.06 to $4.23 range. That is -2% versus the projected 2034 average. That marks a +66% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, INDP could reach as high as $5.22, with a base case around $2.37 and support toward $1.07 — roughly +87% from $1.27. Momentum favours further upside here.
Expect INDP to range from $1.98 to $10.12 through 2050. The $4.40 average target implies a +247% move from current prices. That is up +85% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in INDP today (≈ 787.401575 INDP) could be worth
$3,466.04
+$2,466.04 (+247%) by 2050 · US Dollar
Based on the average projected INDP price of $4.4 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INDPwould be worth at today's price.
$1,000 invested in INDP on May 27, 2025 (≈ 110.229282 INDP) would be worth
$139.99
-$860.01 (-86.0%) today · 0.14× · US Dollar
Based on a INDP entry price of $9.07 vs. today's $1.27.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.23 | $1,032.52 | +3.3% |
| 1 month ago | $3.43 | $370.26 | -63.0% |
| 3 months ago | $2.06 | $615.61 | -38.4% |
| 6 months ago | $2.23 | $569.51 | -43.0% |
| 1 year ago | $9.07 | $139.99 | -86.0% |
| All time (5.0y) ago | $421.12 | $3.02 | -99.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INDP forecast.
Our base-case forecast reaches $2.50 around 2050.
Implied market cap at $2.50: $283.11M
The multi-year forecast shows a path of gradual but meaningful upside from current levels. For 2027 the expected average price is $1.54 with a 26 value for ROI, and for 2028 the average rises to $1.63 with a 33.9 ROI. The 2030 forecast projects an average of $1.41 with a 15.3 ROI, followed by a Neutral outlook for 2031 ($1.30) with a 6.5 ROI, and 2032 ($1.36) with an 11.4 ROI.
In 2033 the average price is $1.89 with a 54.9 ROI and a Bullish sentiment, then 2034 at $2.08 with a 70.8 ROI and Bullish, and 2035 at $2.02 with a 65.8 ROI and Bullish. The horizon extends to 2040 with an average of $2.32 and a 90 ROI and Bullish, and to 2050 with an average of $4.22 and a 246.3 ROI and Bullish. These figures illustrate a long-run upside potential, tempered by periods of Neutral sentiment and varying downside/volatility risk; they are estimates and not guarantees.
Tap a question to reveal the answer.
2030 avg $1.41; min $0.8645; max $2.45; ROI 15.3; sentiment NEUTRAL.
Forecasts show a mix of Neutral and Bullish years, with notable upside in years such as 2033 (avg $1.89, ROI 54.9) and 2040 (avg $2.32, ROI 90) and 2050 (avg $4.22, ROI 246.3). However, other years show lower or neutral returns, and these figures are estimates, not guarantees.
The forecast max for 2040 is $5.10, and the 2050 max is $9.72, indicating potential for higher price levels by 2040 or 2050, though these are not guaranteed.
Current price is $1.22 and market cap is $138.16M.
Sentiment is NEUTRAL with RSI14 at 30. The SMA50 is $2.11 and the SMA200 is $2.93. The 30-day range runs from $0.7565 to $1.97, with support at $1.06 and resistance at $3.61.
Indaptus Therapeutics, Inc. Community Discussion
0Share your Indaptus Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.